Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs

North East
22 April 2014 14:36


Exclusive vacancies may not be shown here, please contact Kirsty on +44 1494 818040 or kirstym@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Kirsty Morris
Senior Account Manager
kirstym@zenopa.com
+44 1494 818040

Testimonials
One of the frustrations from the candidate side is when communication stops and you do not know whether the role is still live or not.
Tony, 2011

Boston Scientific launches new Mustang PTA balloon catheter

23 June 2011 00:00 in Medical Company Product News


Boston Scientific has launched a new balloon catheter for use in percutaneous transluminal angioplasty (PTA) worldwide.

Available now in the US, Europe and other international markets, the Mustang device is a highly deliverable 0.035-inch unit that has been designed in response to demand for a low-profile, high-pressure balloon catheter in a range of sizes.

It utilises Boston Scientific's NyBax Balloon Material to provide high-pressure, non-compliant dilatation, excellent rated burst pressure and compatibility with a 5 French introducer sheath.

The manufacturer states that the Mustang device, which is available in 203 size variants, will be applicable to a variety of lesions of different complexities.

Joe Fitzgerald, senior vice-president and president of Boston Scientific's endovascular unit, said: "Its versatility and extensive size matrix allow physicians to address nearly every peripheral need, ranging from treating blockages in femoral arteries to dialysis fistulae."

This follows on from the launch of its Energen and Punctua cardiac resynchronisation therapy defibrillators and implantable cardioverter defibrillators in Europe last month.ADNFCR-8000103-ID-800597505-ADNFCR

Other news stories from 23/06/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd